XRHealth, a provider of VR/XR therapeutic solutions, has acquired NeuroReality and its flagship product, Koji's Quest, for an undisclosed sum.
NeuroReality offers virtual reality tools for cognitive training. Its Koji's Quest product provides customizable programs for rehabilitation needs, including stroke, long-term Covid, traumatic brain injury, neurodevelopmental issues, neurodegenerative issues, dementia, and healthy aging.
The acquisition aims to expand XRHealth's therapeutic offerings and strengthen its position as a leading XR therapeutic platform, allowing the company to provide a more comprehensive and engaging set of tools for therapy and rehabilitation.
Analyst QuickTake: XRHealth and NeuroReality initially partnered in September 2022 to offer the Koji Quest solution via XRHealth's virtual clinics. Through the integration, it appears that the combined solution became an integral part of XRHealth's offering, prompting the acquisition of NeuroReality to maintain a competitive edge in the space.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.